General Information of the Compound
Compound ID
CP0042804
Compound Name
(2R,3S)-N*4*-Hydroxy-2-isobutyl-N*1*-((S)-1-methylcarbamoyl-2-phenyl-ethyl)-3-(thiophen-2-ylsulfanylmethyl)-succinamide
    Show/Hide
Synonyms
(2S,3R)-5-Methyl-3-(((alphaS)-alpha-(methylcarbamoyl)phenethyl)carbamoyl)-2-((2-thienylthio)methyl)hexanohydroxamic acid
130370-60-4
4-(N-HYDROXYAMINO)-2R-ISOBUTYL-2S-(2-THIENYLTHIOMETHYL)SUCCINYL-L-PHENYLALANINE-N-METHYLAMIDE
BB 94
BB-94
BB94
BK349F52C9
Batimastat
Batimastat (BB-94)
Batimastat(BB-94)
Butanediamide, N4-hydroxy-N1-(2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl)-2-(2-methylpropyl)-3-((2-thienylthio)methyl)-, (2R-(1(S*),2R*,3S*))-
C23H31N3O4S2
CHEMBL279786
UNII-BK349F52C9
batimastat
    Show/Hide
Structure
Formula
C23H31N3O4S2
Molecular Weight
477.652
Canonical SMILES
CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)[C@H](CSc1cccs1)C(=O)NO
    Show/Hide
InChI
InChI=1S/C23H31N3O4S2/c1-15(2)12-17(18(22(28)26-30)14-32-20-10-7-11-31-20)21(27)25-19(23(29)24-3)13-16-8-5-4-6-9-16/h4-11,15,17-19,30H,12-14H2,1-3H3,(H,24,29)(H,25,27)(H,26,28)/t17-,18+,19+/m1/s1
    Show/Hide
InChIKey
XFILPEOLDIKJHX-QYZOEREBSA-N
CAS
130370-60-4
Physicochemical Property
logP
3.0976
Rotatable Bonds
12
Heavy Atom Count
32
Polar Areas
107.53
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
6
Complexity
32

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 5362422
SID: 12014769
ChEMBL ID
CHEMBL279786
DrugBank ID
DB03880
Clinical Information about the Compound
Drug 1 ( Batimastat )
Drug Name Batimastat
Company Pfizer
Indication
Idiopathic pulmonary fibrosis
Preclinical
Target(s)
Matrix metalloproteinase-3 (MMP-3)
Modulator